These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8282288)

  • 21. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonist.
    Petrie JR; Glen SK; MacMahon M; Crome R; Meredith PA; Elliott HL; Reid JL
    J Hypertens; 1995 Dec; 13(12 Pt 2):1842-6. PubMed ID: 8903664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical pharmacology of beta-adrenergic blockers.
    Lowenthal DT
    Cardiovasc Clin; 1984; 14(3):61-71. PubMed ID: 6144391
    [No Abstract]   [Full Text] [Related]  

  • 23. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells.
    Hoffman S; Gopalakrishna R; Gundimeda U; Murata T; Spee C; Ryan SJ; Hinton DR
    Exp Eye Res; 1998 Jul; 67(1):45-52. PubMed ID: 9702177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of calcium channel blocking on immune capacity of cardiovascular patients.
    Lehtonen LA; Eskola JT; Gordin A; Erkko MK; Räihä IJ; Lehtonen AA
    J Clin Lab Immunol; 1989 Oct; 30(2):75-80. PubMed ID: 2641532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of age on pharmacokinetics and pharmacodynamics in man.
    Klotz U
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):581-5. PubMed ID: 9849746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Elements of pharmacodynamics and pharmacokinetics].
    Piette F; Soubrie C
    Rev Prat; 1990 May; 40(15):1359-65. PubMed ID: 2356424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Calcium antagonists, not long acting].
    Fernández Rodríguez A; Camarasa García F; Camino Calderón E; Puras Tellaeche A
    An Med Interna; 1998 Mar; 15(3):173-4. PubMed ID: 9567430
    [No Abstract]   [Full Text] [Related]  

  • 29. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].
    Sarfati Y; Spadone C; Vanelle JM; Lôo H
    Encephale; 1996; 22(2):149-53. PubMed ID: 8706625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain.
    Sequeira RP; Jassim Al Khaja KA; Mathur VS
    J Postgrad Med; 2002; 48(3):172-5. PubMed ID: 12432188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD
    Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
    [No Abstract]   [Full Text] [Related]  

  • 33. Calcium antagonists in comparison: view of the pharmacologist.
    Borchard U
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S85-91. PubMed ID: 7898100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D; Croci D; Mamoli D; Messina S; Perucca E
    Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical, hemodynamic and hormonal-metabolic effects of the calcium-antagonist treatment of middle-aged and elderly patients with IHD at the polyclinic stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD; Dudarev MV
    Ter Arkh; 1996; 68(1):42-5. PubMed ID: 8644030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging the gap: ageing, pharmacokinetics and pharmacodynamics.
    Burton DG; Allen MC; Bird JL; Faragher RG
    J Pharm Pharmacol; 2005 Jun; 57(6):671-9. PubMed ID: 15969921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of m-nifedipine in rabbits after intravenous injection.
    Ma J; Xie JW; Jia ZP; Song L; Xu SY; Zhao DH
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):109-11. PubMed ID: 9772655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
    Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
    Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.